HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis.

Abstract
We examined the activities of peptidases in plasma and tissues of the New Zealand Black (NZB) mouse as an animal model of human systemic lupus erythematosus, and also in serum from patients with rheumatoid arthritis and systemic lupus erythematosus. Activities of dipeptidyl peptidase II (DAP II) and post-proline cleaving enzyme (PPCE) were increased, and dipeptidyl peptidase IV (DAP IV) activity was decreased in plasma and spleen of NZB mice, as compared with the control BALB/c mice. Likewise, the activity of DAP II was increased and that of DAP IV was decreased in serum of patients with rheumatoid arthritis and systemic lupus erythematosus. These results indicate the importance of hydrolytic enzymes in the pathogenesis of autoimmune diseases.
AuthorsM Hagihara, M Ohhashi, T Nagatsu
JournalClinical chemistry (Clin Chem) Vol. 33 Issue 8 Pg. 1463-5 (Aug 1987) ISSN: 0009-9147 [Print] England
PMID2886236 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Endopeptidases
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
  • dipeptidyl peptidase II
  • Dipeptidyl Peptidase 4
  • Serine Endopeptidases
  • PREPL protein, human
  • Prolyl Oligopeptidases
Topics
  • Animals
  • Arthritis, Rheumatoid (complications, enzymology)
  • Dipeptidyl Peptidase 4
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases (analysis)
  • Endopeptidases (analysis)
  • Female
  • Humans
  • Kidney (enzymology)
  • Lupus Erythematosus, Systemic (complications, enzymology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred NZB
  • Prolyl Oligopeptidases
  • Serine Endopeptidases
  • Spleen (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: